Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
262 pending office actions • 107 art units • 230 examiners • 0 of 262 (0%) have an AI response strategy ready • 170 patents granted in the last 365 days
The Board of Regents of the University of Texas System manages a large portfolio of 260 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 228 distinct examiners and 105 distinct art units. The involvement of 105 distinct art units highlights the extreme technical diversity of the university's research and patent filings.
QIAN, CELINE X is the busiest examiner for this system, currently overseeing 3 pending office actions. This is a very low concentration given the total of 260 pending office actions. With 228 distinct examiners, the university must manage a vast array of individual examiner styles and requirements across its biotechnology and pharmaceutical applications.
The high volume of 260 pending office actions combined with 228 distinct examiners suggests that most examiners are only handling a single case for the university. This decentralized environment across 105 distinct art units necessitates a highly organized approach to prosecution to ensure that legal arguments remain consistent across the entire portfolio.
Based on the USPTO statutory response window for each pending office action. 89 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 89 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 4 (2%) |
| §101 + other | 22 (8%) |
| §103 only | 60 (23%) |
| §102 only | 8 (3%) |
| §112 only | 21 (8%) |
| Double-patenting only | 7 (3%) |
| Double-patenting + other | 23 (9%) |
| Multi-statute (no §101) | 114 (44%) |
| No statute on record | 3 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| QIAN, CELINE X | 3 | 47.6% | +16.9% |
| JONES, DAMERON LEVEST | 3 | 67.7% | +31.3% |
| GODDARD, LAURA B | 3 | 50.9% | +13.5% |
| CHONG, KIMBERLY | 3 | 72.4% | +13.0% |
| SPENCE, JENNIFER SUZANNE | 3 | 66.9% | +46.0% |
| ROBINSON, MIKHAIL O'DONNEL | 2 | 59.2% | +42.1% |
| TRAN, VIVIAN AILINH | 2 | 55.2% | +43.0% |
| MCCORMACK, JASON L | 2 | 84.6% | +8.1% |
| AULAKH, CHARANJIT | 2 | 80.6% | -14.5% |
| KNIGHT, TERESA E | 2 | 65.9% | +48.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18895633 | OPERANDO SCANNING ELECTRON MICROSCOPY PLATFORM AND METHODS OF USING THE SAME | MCCORMACK, JASON L | — |
| 18789936 | COLLECTION PROBE AND METHODS FOR THE USE THEREOF | MCCORMACK, JASON L | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17755881 | NATURAL KILLER CELL IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS | EBBINGHAUS, BRIANA NOEL | 217d overdue |
| 18308921 | PROACTIVE SEISMIC REHABILITATION OF WATER PIPE NETWORKS FOR EQUITABLE RECOVERY | ABOUZAHRA, REHAM K | 146d overdue |
| 18696620 | TOOL AND PROCESSES FOR PICK-AND-PLACE ASSEMBLY | KOCH, GEORGE R | 126d overdue |
| 18736011 | System and Methods to Cover the Continuum of Real-time Decision-Making using a Distributed AI-Driven Search Engine on Visual Internet-of-Things | HASAN, SYED HAROON | 110d overdue |
| 18010456 | PROCESSES AND APPLICATIONS FOR CATALYST INFLUENCED CHEMICAL ETCHING | PETERSON, ERIK T | 84d overdue |
| 18069796 | ENCAPSULATION OF BIOACTIVE INGREDIENTS BY MULTIPLEX EMULSION | STEINKE, SEAN JAMES | 73d overdue |
| 18018350 | SOLIDS ANALYSIS OF DRILLING AND COMPLETION FLUIDS | CULLER, JILL E | 72d overdue |
| 18287009 | Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles | SHOMER, ISAAC | 71d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17782976 | EXOSOMES-BASED THERAPY FOR LIVER FIBROSIS AND OTHER DISEASES WITH FIBROSIS | CHONG, KIMBERLY | 66d overdue |
| 17929013 | METHODS FOR RAPID CLONING AND EXPRESSION OF HLA CLASS I CELLS | QIAN, CELINE X | 51d overdue |
| 17756116 | LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF MSC CELLS | SPENCE, JENNIFER SUZANNE | 46d overdue |
| 18041470 | TEXAPHYRIN DERIVATIVES FOR MANGANESE CHEMOTHERAPY, PHOTOACOUSTIC IMAGING, AND PHOTOTHERMAL THERAPY | JONES, DAMERON LEVEST | 21d |
| 17782147 | COMBINATION THERAPIES FOR THE TREATMENT OF CANCER | JONES, DAMERON LEVEST | 39d |
| 17786917 | METHODS FOR TREATING GLIOBLASTOMA | GODDARD, LAURA B | 40d |
| 18944707 | INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE | ROBINSON, MIKHAIL O'DONNEL | — |
| 18861679 | FLEXIBLE MULTIPARAMETRIC PLANT SENSORS AND METHODS OF MAKING AND USING THEREOF | TRAN, VIVIAN AILINH | — |
| Art Unit | Apps |
|---|---|
| 1618 | 8 |
| 1675 | 7 |
| 1612 | 6 |
| 3798 | 5 |
| 1645 | 5 |
| 1643 | 5 |
| 1682 | 5 |
| 1674 | 5 |
| 1632 | 5 |
| 1633 | 5 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19145173 | SYSTEM AND METHODS FOR FIBER-BASED LASER SPECKLE IMAGING | CAMARGO, MARLY S.B. | 2638 | §102§103§112Other | Non-Final OA | — | Pending | Jul 01, 2025 |
| 19205984 | INTEGRATED SMART SYSTEM CONTROLLABLE BY ASYNCHRONOUS EEG BASED BRAINCOMPUTER INTERFACE USING RIEMANNIAN GEOMETRY USING EMBEDDED ROBOTOPERATING SYSTEM | BALAOING, ARIEL A | 2624 | §103 | Final Rejection | — | Pending | May 12, 2025 |
| 19182434 | MODIFIED PLANTS CONTAINING COMBINATION OF APYRASE GENES AND METHOD FOR MAKING MODIFIED PLANTS WITH COMBINATION OF APYRASE GENES | LOGSDON, CHARLES | 1662 | §102§103DP | Non-Final OA | — | Pending | Apr 17, 2025 |
| 19173135 | SYSTEM AND METHOD FOR AUTOMATED ANALYSIS AND DETECTION OF CARDIAC ARRHYTHMIAS FROM ELECTROCARDIOGRAMS | HODGE, LAURA NICOLE | — | §101§103Other | Non-Final OA | — | Pending | Apr 08, 2025 |
| 19106482 | AQUEOUS NANOBUBBLE DISPERSION AND GAS SUPERSATURATION AT ELEVATED PRESSURES | LEFF, ANGELA MARIE DITRAN | 3674 | §102§103 | Final Rejection | — | Pending | Feb 25, 2025 |
| 19045950 | APPARATUS FOR GENERATING THERAPEUTIC SHOCKWAVES AND APPLICATIONS OF SAME | BRUCE, FAROUK A | 3797 | Other | Non-Final OA | 8d | Pending | Feb 05, 2025 |
| 19014996 | Modular, Multicell, and Multilevel Inverter | NASH, GARY A | — | §102 | Non-Final OA | — | Pending | Jan 09, 2025 |
| 19011283 | SYSTEMS AND METHODS TO REDUCE THE DC LINK CAPACITANCE AND IMPROVE THE RELIABILITY OF CONVERTERS | TORRES-RIVERA, ALEX | — | §102§103§112 | Non-Final OA | — | Pending | Jan 06, 2025 |
| 18874393 | VIRTUAL REMOTE TELE-PHYSICAL EXAMINATION SYSTEMS | VILLECCO, JOHN M | — | §103 | Non-Final OA | — | Pending | Dec 12, 2024 |
| 18959959 | METHODS, SYSTEMS, AND DEVICES FOR PAIRING VAGUS NERVE STIMULATION WITH MOTOR THERAPY IN PATIENT WHO HAS HEMIPARESIS | FAIRCHILD, MALLIKA DIPAYAN | — | DP | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18868020 | COMPOSITE MATERIALS AND METHODS OF MAKING AND USE THEREOF | JONES, JAMES | — | §102 | Non-Final OA | — | Pending | Nov 21, 2024 |
| 18949196 | SYSTEMS FOR CYBER-PHYSICAL PASSPORTS AND RELATED METHODS | TORRICO-LOPEZ, ALAN | — | §101§102§103 | Non-Final OA | — | Pending | Nov 15, 2024 |
| 18866377 | ORTHOPEDIC BALL TIP GUIDEWIRE POSITIONING DEVICE | RAMANA, ANURADHA | 3775 | §103§112 | Final Rejection | 16d overdue | Pending | Nov 15, 2024 |
| 18866314 | DUST MITIGATING NANOTEXTURE AND METHOD OF MAKING | MULVANEY, ELIZABETH EVANS | — | §102§103§112 | Non-Final OA | — | Pending | Nov 15, 2024 |
| 18944707 | INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE | ROBINSON, MIKHAIL O'DONNEL | — | §101§103 | Non-Final OA | — | Pending | Nov 12, 2024 |
| 18938730 | IMIDAZOPIPERAZINE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS | JACKSON, SHAWQUIA | — | DP | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18863510 | SYSTEMS AND METHODS FOR IMPROVED TRANSPORT AND DISTRIBUTION OF AGENTS IN AND CHARACTERIZATION OF BIOLOGICAL TISSUE | SHAFQAT, AMY JEANETTE | 3798 | §102§103 | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18932270 | CABLE DESIGN FOR ALL-ELECTRIC AIRCRAFT | MCALLISTER, MICHAEL F | 2847 | §102 | Non-Final OA | — | Pending | Oct 30, 2024 |
| 18861679 | FLEXIBLE MULTIPARAMETRIC PLANT SENSORS AND METHODS OF MAKING AND USING THEREOF | TRAN, VIVIAN AILINH | 1794 | §102§103§112Other | Non-Final OA | — | Pending | Oct 30, 2024 |
| 18860871 | A DILATING AND STENTING ORAL OR NASOPHARYNGEAL AIRWAY | MURPHY, VICTORIA | — | §102§103§112 | Non-Final OA | — | Pending | Oct 28, 2024 |
| 18860498 | CONTINUOUS BLOOD FLOW VISUALIZATION WITH LASER SPECKLE CONTRAST IMAGING | LI, JOHN DENNY | 3798 | §103 | Final Rejection | 14d | Pending | Oct 25, 2024 |
| 18859101 | MICRONEEDLE-BASED PLANT SENSORS AND METHODS OF MAKING AND USING THEREOF | TRAN, VIVIAN AILINH | 1794 | §102§103§112 | Non-Final OA | — | Pending | Oct 22, 2024 |
| 18858186 | REAL-TIME BREATH ADAPTIVE NEBULIZER APPARATUS AND METHODS FOR PULMONARY THERAPEUTIC AGENT DELIVERY | ALBERS, KEVIN S | — | §103§112 | Non-Final OA | — | Pending | Oct 18, 2024 |
| 18857661 | MAGNETICALLY STEERABLE CATHETER | KOLKIN, ADAM D. | 3798 | §103 | Non-Final OA | 7d | Pending | Oct 17, 2024 |
| 18911658 | SOLID-STATE SILVER SORBENTS FOR OLEFIN ADSORPTION | ROBINSON, RENEE E | — | §103 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18911908 | ISOTOPOLOGUE MARKER FOR FLUID RESOURCES OR POLLUTANTS | HINES, LATOSHA D | 1771 | §103 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18909200 | LINE EXCITATION ARRAY DETECTION MICROSCOPY | LAVARIAS, ARNEL C | — | §112 | Non-Final OA | — | Pending | Oct 08, 2024 |
| 18895633 | OPERANDO SCANNING ELECTRON MICROSCOPY PLATFORM AND METHODS OF USING THE SAME | MCCORMACK, JASON L | — | §112 | Non-Final OA | — | Pending | Sep 25, 2024 |
| 18849399 | METHODS OF PREPARING CARRIER-BASED DRY POWDERS FOR INHALATION | PALENIK, JEFFREY T | — | §103 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18891981 | MACHINE AND PROCESS FOR INSERTING A PROBE IN A BRAIN | FERNANDEZ, KATHERINE L | 3798 | §103 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18843651 | METHODS OF TREATING CANCER WITH IAP ANTAGONIST COMPOUNDS AND COMBINATION THERAPIES | AULAKH, CHARANJIT | — | §102§103 | Non-Final OA | — | Pending | Sep 03, 2024 |
| 18818538 | TUNED MATERIALS, TUNED PROPERTIES, AND TUNABLE DEVICES FROM ORDERED OXYGEN VACANCY COMPLEX OXIDES | KIM, JAY C | — | §112 | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18811575 | PHOSPHONIUM-BEARING CONJUGATED POLYELECTROLYTES | OH, TAYLOR V | — | §112 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18799303 | PTPN11 INHIBITORS | WARD, PAUL V | — | DP | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18789888 | BIOCHEMICAL AND BIOMECHANICAL CONDITIONING FOR ENHANCING PERSONALIZED MESENCHYMAL STEM CELL THERAPIES | KNIGHT, TERESA E | — | DP | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18789936 | COLLECTION PROBE AND METHODS FOR THE USE THEREOF | MCCORMACK, JASON L | — | §103DP | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18790675 | DIGITAL LIGHT FOUR-DIMENSIONAL PRINTING OF PROGRAMMABLE MORPHOLOGY AND MOTION STRUCTURES | LIANG, ANTHONY M | 1734 | §112 | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18787216 | INHIBITORS OF MUTANT IDH1 AND IDH2 | ROBINSON, MIKHAIL O'DONNEL | — | §112 | Non-Final OA | — | Pending | Jul 29, 2024 |
| 18773701 | WEARABLE OPTICAL E-TATTOO FOR ARTERIAL AND VENOUS BLOOD OXYGENATION MONITORING | PARK, EVELYN GRACE | 3791 | §101§103§112 | Non-Final OA | — | Pending | Jul 16, 2024 |
| 18728885 | HIGH-PRECISION HETEROGENEOUS INTEGRATION | JOHNSON, CHRISTOPHER A | — | §102§103§112 | Non-Final OA | — | Pending | Jul 14, 2024 |
| 18728323 | METHODS AND SYSTEMS FOR DETERMINING LEUKEMIA OR LYMPHOMA LEVELS USING LYMPHOID IMAGES | JOHNSON, NICOLE F | 3796 | §103 | Final Rejection | 8d | Pending | Jul 11, 2024 |
| 18766484 | SYNTHESIS AND FABRICATION OF MECHANICALLY ROBUST AND MESOPOROUS ABAC TETRABLOCK POLYMER MEMBRANES FOR ULTRAFILTRATION | EZELUOMBA, MIRIAM NCHEKWUBECHU | — | §102§103§112 | Non-Final OA | — | Pending | Jul 08, 2024 |
| 18763115 | APPARATUS AND METHODS FOR COMPUTATIONALLY INFORMED ADHESION MEASUREMENT USING THE BLISTER TEST | DEVITO, ALEX T | — | §102§103 | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18725495 | POTENT AND SELECTIVE SMARCA2 DEGRADING CHIMERIC MOLECULES AS CANCER THERAPEUTICS | HEITMEIER, KENDALL NICOLE | — | §103§112 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18757031 | INTEGRATED ELECTRODE AND CABLE STRUCTURE | AZAM, MUHAMMED | 2847 | §102§103§112 | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18719116 | REVERSAL OF SENESCENCE BY ULTRASOUND IRRADIATION | CWERN, JONATHAN | 3797 | §102§103 | Final Rejection | — | Pending | Jun 12, 2024 |
| 18717529 | PHARMACEUTICAL COMBINATION COMPRISING ABEMACICLIB AND A PI3K AND/OR A MTOR INHIBITOR FOR THE TREATMENT OF MANTLE CELL LYMPHOMA | VISHNYAKOVA, ELENA VLADIMIROVNA | — | §102§103§112 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18736011 | System and Methods to Cover the Continuum of Real-time Decision-Making using a Distributed AI-Driven Search Engine on Visual Internet-of-Things | HASAN, SYED HAROON | 2154 | §101§103 | Non-Final OA | 110d overdue | Pending | Jun 06, 2024 |
| 18734176 | CYCLIC DINUCLEOTIDES AS AGONISTS OF STIMULATOR OF INTERFERON GENE DEPENDENT SIGNALLING | DAVIS, BRIAN J | 1614 | §102§112 | Non-Final OA | — | Pending | Jun 05, 2024 |
| 18716052 | GLUCOCORTICOID RECEPTOR BLOCKADE WITH MIFEPRISTONE TO SENSITIZE PANCREATIC CANCER TO IMMUNOTHERAPY | AULAKH, CHARANJIT | — | §102§103§112 | Non-Final OA | — | Pending | Jun 03, 2024 |
| 18714512 | MULTI-TARGETED, MODULAR VIRUS SENSING PLATFORM | KIPOUROS, HOLLY MICHAELA | — | §112 | Non-Final OA | — | Pending | May 29, 2024 |
| 18705061 | DRY POWDER COMPOSITIONS COMPRISING EUKARYOTIC CELLS AND METHOD OF THEIR MANUFACTURE AND USE | GEMBEH, SHIRLEY V | 1615 | §102§103 | Final Rejection | 70d | Pending | Apr 26, 2024 |
| 18642504 | SYSTEM AND METHODS FOR UNBIASED TRANSFORMER SOURCE CODE VULNERABILITY LEARNING WITH SEMANTIC CODE GRAPH | DOAN, TAN | 2445 | §103 | Final Rejection | 98d overdue | Pending | Apr 22, 2024 |
| 18641072 | ULTRASOUND-GUIDED OPTOACOUSTIC MONITORING OF OXYGEN SATURATION | DAVIS, AMELIE R | 3798 | §102§103 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18701303 | Compositions and Methods for Modulating Mitochondrial Function | ROBERTS, LEZAH | 1612 | §102§103§112 | Final Rejection | 63d | Pending | Apr 15, 2024 |
| 18701465 | FACILE DIRECT AMINATION AND ALKYLAMINATION OF CARBON NANOTUBES | RHOADES, DEREK JAMES | — | §102§103§112DP | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18634454 | FORMATION OF STABLE SUBMICRON PEPTIDE OR PROTEIN PARTICLES BY THIN FILM FREEZING | BECKHARDT, LYNDSEY MARIE | 1613 | §103§112DP | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18699702 | ENGINEERING NK CELLS WITH A CAR CONSTRUCT WITH OPTIMAL SIGNALING | HAM, JIEUN | — | §102§103§112DP | Non-Final OA | — | Pending | Apr 09, 2024 |
| 18697325 | ENGINEERED VECTORS AND ORGANISMS CONTAINING THE SAME FOR ISOFLAVONE CONVERSION IN THE GUT | OGUNBIYI, OLUWATOSIN A | 1645 | §103 | Non-Final OA | 9d | Pending | Mar 29, 2024 |
| 18696620 | TOOL AND PROCESSES FOR PICK-AND-PLACE ASSEMBLY | KOCH, GEORGE R | 1745 | §103§112 | Final Rejection | 126d overdue | Pending | Mar 28, 2024 |
| 18613203 | Small Molecule Targeting of BRD4 for Treatment of COVID-19 | VALENROD, YEVGENY | 1628 | §103 | Final Rejection | — | Pending | Mar 22, 2024 |
| 18605320 | Compositions of Azadirachta Indica and Methods of Treating Cancer | ROMERO, KRISTEN WANG | 1624 | §103§112 | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18604733 | N,N'-DIPHENYL-4,4'-BIPHENYLDICARBOXAMIDE ANALOGS AND THEIR USE IN CANCER TREATMENT | SZNAIDMAN, MARCOS L | 1628 | §102§112 | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18691626 | IDENTIFYING OBJECTS IN MAGNETIC RESONANCE IMAGES | ROBERTS, RACHEL L | 2674 | §103 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18688180 | COMPOSITIONS AND METHODS FOR TREATING BONE INJURIES | MEYERS, ELIZABETH ANNE | 1617 | §103§112DP | Final Rejection | 19d overdue | Pending | Feb 29, 2024 |
| 18683988 | CRISPR-ASSOCIATED TRANSPOSONS AND USES THEREOF | QIAN, CELINE X | — | §102§103§112 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18436313 | SYSTEMS AND METHODS FOR STRESS DETECTION USING KINEMATIC DATA | PHUNG, STEVEN HUYNH | — | §101§102§103§112 | Non-Final OA | — | Pending | Feb 08, 2024 |
| 18294680 | MODIFIED NUCLEIC ACID COMPOSITIONS AND ASSOCIATED METHODS FOR TREATMENT OF PHENYLKETONURIA | WHITEMAN, BRIAN A | — | §102§103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18293144 | METHODS AND COMPOSITIONS FOR TREATMENT OF KRAS MUTANT CANCER | MOU, LIYUAN | 1624 | §102§103§112DP | Non-Final OA | — | Pending | Jan 29, 2024 |
| 18291539 | DIAGNOSTIC PLATFORM FOR ANALYZING AND OPTIMIZING WELL TREATMENT FLUIDS | GZYBOWSKI, MICHAEL STANLEY | — | §103§112 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18414651 | SYSTEM AND METHOD FOR EVALUATING AND COACHING SOCIAL COMPETENCIES IN IMMERSIVE VIRTUAL ENVIRONMENTS | LANE, DANIEL E | 3715 | §101§102§103§112 | Final Rejection | 23d overdue | Pending | Jan 17, 2024 |
| 18576920 | SEPARATORS FOR USE IN ENERGY STORAGE DEVICES | ERWIN, JAMES M | — | §102§103§112 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18576848 | SPRAYED MULTI ADSORBED-DROPLET REPOSING TECHNOLOGY (SMART) | MELENDEZ, ARMAND | 2117 | §102§103 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18571833 | ANTIBODIES SPECIFIC TO NELL2 AND METHODS OF USE | ALSOMAIRY, SARAH ABDOALATIF | — | §112 | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18570151 | Method to Identify Patterns in Brain Activity | MALAMUD, DEBORAH LESLIE | 3792 | §101§103§112 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18569842 | MORPHABLE BONE FIXATION DEVICE, SYSTEM AND METHOD | JOHANAS, JACQUELINE T | 3773 | §102§103§112 | Final Rejection | 22d | Pending | Dec 13, 2023 |
| 18567967 | POLYPEPTIDES TARGETING CD70-POSITIVE CANCERS | KAUFMAN, CLAIRE M | — | §112 | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18530775 | SILYL-BIARYL PHOSPHORAMIDITES AND METHODS OF MAKING | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §102 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18566362 | DRUG-ELUTING TUBES FOR IMPROVED PATIENT CARE | WRUBLESKI, MATTHEW JAMES | 3781 | §103 | Final Rejection | 23d | Pending | Dec 01, 2023 |
| 18566011 | METHODS AND COMPOSITIONS RELATED TO ENGINEERED BIOSENSORS | QIAN, CELINE X | — | §102§112 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18566008 | COMPOSITIONS OF CLOFAZIMINE AND AMIKACIN FOR PULMONARY ADMINISTRATION IN THE TREATMENT OF RESPIRATORY DISEASES | RAHMANI, NILOOFAR | 1691 | §103 | Final Rejection | 5d | Pending | Nov 30, 2023 |
| 18566018 | METHODS AND COMPOSITIONS RELATED TO A MODIFIED METHYLTRANSFERASE | BREEN, KIMBERLY CATHERINE | — | §101§103§112 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 17998911 | METHODS FOR THE TREATMENT OF PANCREATITIS AND PREVENTION OF PANCREATIC CANCER | SEAMAN, D MARGARET M | 1625 | §102§112 | Non-Final OA | — | Pending | Nov 15, 2023 |
| 18560746 | CHIMERIC POLYPEPTIDES AND METHODS OF USE | CHATTIN, AMY MARIE | 1643 | §102§103 | Non-Final OA | — | Pending | Nov 14, 2023 |
| 18560791 | CHIMERIC ANTIGEN RECEPTOR TO TARGET HLA-G-POSITIVE CANCERS | WANG, CHANG YU | 1675 | §102§103§112 | Non-Final OA | — | Pending | Nov 14, 2023 |
| 18506636 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HUMAN CHLAMYDIAL INFECTIONS AND DISEASES USING ATTENUATED ANIMAL CHLAMYDIA | DUFFY, PATRICIA ANN | 1645 | §112 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18559667 | PRODUCTION OF THERAPEUTIC MESENCHYMAL STEM CELL-DERIVED EXOSOMES | NGUYEN, QUANG | 1631 | §103DP | Final Rejection | — | Pending | Nov 08, 2023 |
| 18504509 | METHODS, APPARATUSES, AND SYSTEMS FOR ASPIRATING AIRWAYS | LE, QUYNH DAO | 3781 | §103 | Final Rejection | 8d overdue | Pending | Nov 08, 2023 |
| 18559460 | METHODS AND COMPOSITIONS FOR TRANSPORT, STORAGE, AND DELIVERY OF ADENO-ASSOCIATED VIRAL VECTOR AND OTHER MOLECULES | KNIGHT, TERESA E | 1634 | §103 | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18559146 | INHIBITORY CHIMERIC ANTIGEN RECEPTOR PREVENTS ON-TARGET OFF-TUMOR EFFECTS OF ADOPTIVE CELL THERAPY | JUEDES, AMY E | 1644 | §102§103 | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18558882 | DOUBLE SIDED CHIMERIC ANTIGEN RECEPTOR (CAR) ENGINEERED CELL MEMBRANE BASED DRUG DELIVERY SYSTEMS | NATARAJAN, MEERA | 1643 | §102§112 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18287009 | Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles | SHOMER, ISAAC | 1612 | §103§112 | Non-Final OA | 71d overdue | Pending | Oct 15, 2023 |
| 18379746 | SYSTEMS, APPARATUS, AND METHODS FOR BIT LEVEL REPRESENTATION FOR DATA PROCESSING AND ANALYTICS | JEBARI, MOHAMMED | 2482 | §102§103 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18554403 | COMPOUNDS AND METHODS FOR THERANOSTIC TARGETING OF PARP ACTIVITY | DONOHUE, SEAN R | 1618 | §103§112 | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18554389 | METHODS AND SYSTEMS FOR HPV DETECTION AND QUANTIFICATION | DAUNER, JOSEPH G | 1682 | §101§102§103 | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18554180 | METHODS AND COMPOSITIONS COMPRISING MHC CLASS I PEPTIDES | PAGONAKIS, ANNA | 6221 | §102§103§112 | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18285205 | CITRULLINATED PROTEINS AS BIOMARKERS AND THERAPY TARGETS FOR CANCER | DUNN, LINDSAY MICHELLE | 1644 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18283408 | METHODS AND COMPOSITIONS FOR TREATING CANCER THERAPY-INDUCED NEUTROPENIC FEVER AND/OR GVHD | SHIAO, YIH-HORNG | 1691 | §102§103§112 | Non-Final OA | — | Pending | Sep 21, 2023 |
| 18470177 | DYNAMIC ADAPTIVE SCHEDULING FOR ENERGY-EFFICIENT HETEROGENEOUS SYSTEMS-ON-CHIP AND RELATED ASPECTS | EWALD, JOHN ROBERT DAKITA | 2199 | §103 | Final Rejection | 11d overdue | Pending | Sep 19, 2023 |
| 18550484 | METHODS FOR ACTIVATION AND EXPANSION OF NATURAL KILLER CELLS AND COMBINATIONS WITH BISPECIFIC ANTIBODIES | SANG, HONG | 1646 | §102§103§112DP | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18549645 | DRY POWDER FORMULATIONS OF NUCLEIC ACID LIPID NANOPARTICLES | SHOMER, ISAAC | 1612 | §102§103 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18463282 | USE OF SDHA AS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET IN UVEAL MELANOMA | SALMON, KATHERINE D | 1682 | §103 | Final Rejection | 161d overdue | Pending | Sep 07, 2023 |
| 18280427 | Loading of Alginate Microspheres | BAEK, JONGHWAN NMN | 1618 | §102§103 | Final Rejection | 75d | Pending | Sep 05, 2023 |
| 18548865 | METHODS AND SYSTEMS FOR DIAGNOSIS, CLASSIFICATION, AND TREATMENT OF SMALL CELL LUNG CANCER AND OTHER HIGH-GRADE NEUROENDOCRINE CARCINOMAS | HANEY, AMANDA MARIE | 1682 | §103§112 | Final Rejection | — | Pending | Sep 01, 2023 |
| 18457034 | METHODS, COMPOSITIONS, AND DEVICES FOR THE OCCLUSION OF CAVITIES AND PASSAGEWAYS | IGBOKO, CHIMA U | 3771 | §102Other | Final Rejection | 41d | Pending | Aug 28, 2023 |
| 18547495 | METHODS FOR PROGNOSING, DIAGNOSING, AND TREATING COLORECTAL CANCER | WOOLWINE, SAMUEL C | 1681 | §103§112 | Final Rejection | 52d overdue | Pending | Aug 22, 2023 |
| 18449351 | HIGH-THROUGHPUT IMAGING PLATFORM | HYUN, PAUL SANG HWA | 1796 | §102§112 | Non-Final OA | — | Pending | Aug 14, 2023 |
| 18546141 | LOW INTENSITY ULTRASOUND COMBINATION CANCER THERAPIES | MACFARLANE, STACEY NEE | 1675 | §103§112 | Non-Final OA | 26d | Pending | Aug 11, 2023 |
| 18264457 | LITHIATED METAL ORGANIC FRAMEWORKS WITH A BOUND SOLVENT FOR SECONDARY BATTERY APPLICATIONS | LI, AIQUN | 1766 | §102 | Non-Final OA | — | Pending | Aug 07, 2023 |
| 18263341 | METHODS OF TREATING CANCER WITH KINASE INHIBITORS | MOU, LIYUAN | 1628 | §102§112DP | Non-Final OA | — | Pending | Jul 27, 2023 |
| 18359521 | EXOSUIT DEVICE AND METHOD FOR EXOSUIT MODELING AND DESIGN | MILLER, DANIEL A | 3786 | §103§112 | Final Rejection | 5d | Pending | Jul 26, 2023 |
| 18262338 | Gut Microbiome as a Predictive Biomarker of Outcomes for Chimeric Antigen Receptor T-Cell Therapy | MOEHLMAN, ANDREW TERRY | 1655 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 20, 2023 |
| 18271511 | COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, AND JOINT AND TENDON DISORDERS | TAYLOR, LIA ELAN | 1641 | §102§103§112DP | Non-Final OA | — | Pending | Jul 10, 2023 |
| 18260891 | CROSS-REACTIVE ANTIBODIES RECOGNIZING THE CORONAVIRUS SPIKE S2 DOMAIN | MELCHIOR, JAMES RYLAND | 1644 | §112 | Non-Final OA | — | Pending | Jul 10, 2023 |
| 18210829 | LIVE ATTENUATED ZIKA VIRUS WITH 3'UTR DELETION, VACCINE CONTAINING AND USE THEREOF | SALVOZA, M FRANCO G | 1672 | §102§103DP | Final Rejection | 6d | Pending | Jun 16, 2023 |
| 18256897 | COMPOSITIONS AND METHODS OF MAKING COCRYSTALS USING DIELECTRIC HEATING WITH DISPERSIVE AND DISTRIBUTIVE MIXING | COHEN, MICHAEL P | 1612 | §102§103§112 | Non-Final OA | — | Pending | Jun 09, 2023 |
| 18256442 | METHODS AND SYSTEMS FOR SELECTING CONDITIONS FOR MAKING INHALATION FORMULATIONS | KALLAL, ROBERT JAMES | — | §101§103§112 | Non-Final OA | — | Pending | Jun 08, 2023 |
| 18330483 | POWERED PROSTHESIS WITH TORQUE DENSE, LOW RATIO ACTUATION | PATEL, AREN | 3774 | §103 | Non-Final OA | 85d overdue | Pending | Jun 07, 2023 |
| 18330563 | SUMO Targeting Morpholinos as both Enhancers of Anti-Cancer Effects of Chemotherapeutic Treatments and Preventative Agents Against the Establishment of Chemoresistance | SU-TOBON, QIWEN NMN | 1636 | §103§112 | Final Rejection | 6d | Pending | Jun 07, 2023 |
| 18036263 | SYSTEMS AND METHODS FOR THINNING TRANSITION METAL DICHALCOGENIDES | CONTRERAS, CIEL P | 1794 | §102§103 | Non-Final OA | — | Pending | May 10, 2023 |
| 18252005 | METHODS AND SYSTEMS FOR CLASSIFICATION AND TREATMENT OF SMALL CELL LUNG CANCER | HOWARD, ZACHARY C | 1674 | §102§112 | Non-Final OA | — | Pending | May 05, 2023 |
| 18308921 | PROACTIVE SEISMIC REHABILITATION OF WATER PIPE NETWORKS FOR EQUITABLE RECOVERY | ABOUZAHRA, REHAM K | 3625 | §101 | Non-Final OA | 146d overdue | Pending | Apr 28, 2023 |
| 18033464 | ANTIBODIES FOR USE IN THE DETECTION AND TREATMENT OF HEART DISEASE | MERTZ, PREMA MARIA | 1674 | §112 | Final Rejection | — | Pending | Apr 24, 2023 |
| 18250107 | BRAIN PENETRATING PEPTIDES | BORGEEST, CHRISTINA M | 1675 | §102§103§112 | Final Rejection | — | Pending | Apr 21, 2023 |
| 18132324 | PROCESSES AND APPLICATIONS FOR CATALYST INFLUENCED CHEMICAL ETCHING | PETERSON, ERIK T | 2898 | §102§103§112 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18296755 | EXOSOME ENCODED IL-10 AS A TREATMENT FOR INFLAMMATION ASSOCIATED ADVERSE PREGNANCY CONDITION | ABBAS, SYED JARAR | 1674 | §102§103§112 | Final Rejection | 5d overdue | Pending | Apr 06, 2023 |
| 18248193 | PRODUCTION OF MEGAKARYOCYTES AND PLATELETS IN A CO-CULTURE SYSTEM | GRABER, JAMES J | 1631 | §102§103§112 | Final Rejection | 5d | Pending | Apr 06, 2023 |
| 18193917 | METHODS FOR THE DETECTION AND TREATMENT OF LUNG CANCER | AEDER, SEAN E | 1642 | §103Other | Non-Final OA | — | Pending | Mar 31, 2023 |
| 18029293 | ATMOSPHERIC WATER HARVESTING SYSTEM | KUMAR, PREETI | 1761 | §103 | Non-Final OA | 31d overdue | Pending | Mar 29, 2023 |
| 18124132 | LIGHT EMITTING DIODE (LED) STRUCTURES FOR A MICROLED DEVICE, AND METHOD FOR PRODUCING AN ARRAY OF LED STRUCTURES | SMITH, BRADLEY | 2817 | §102§103 | Non-Final OA | 16d overdue | Pending | Mar 21, 2023 |
| 18186443 | COMPOSITIONS AND METHODS FOR CAS9 MOLECULES WITH IMPROVED GENE EDITING PROPERTIES | HUTSON, RICHARD G | 1652 | §102§112 | Final Rejection | — | Pending | Mar 20, 2023 |
| 18044877 | PHARMACEUTICAL COMPOSITIONS OF NICLOSAMIDE AND A PROTEIN | BASQUILL, SEAN M | 1614 | §103 | Final Rejection | 16d overdue | Pending | Mar 10, 2023 |
| 18174732 | INDIUM BASED SOL-GEL OXIDE PRECURSOR FILMS AS EXTREME ULTRAVIOLET AND LOW-ENERGY ELECTRON BEAM RESISTS | TRAYWICK, ANDREW PRESTON | 1737 | §103 | Final Rejection | 184d overdue | Pending | Feb 27, 2023 |
| 18042362 | METHODS OF DEPOSITING FILMS WITH THE SAME STOICHIOMETRIC FEATURES AS THE SOURCE MATERIAL | BRATLAND JR, KENNETH A | 1714 | §102§103 | Non-Final OA | 8d overdue | Pending | Feb 21, 2023 |
| 18041475 | METHOD OF PRODUCING PHARMACEUTICAL COCRYSTALS FOR ADDITIVE MANUFACTURING | BAUER, NICOLA MARIA | 1621 | §102§103§112 | Non-Final OA | — | Pending | Feb 13, 2023 |
| 18041479 | PHARMACEUTICAL COMPOSITION CONTAINING COCRYSTALS FOR ADDITIVE MANUFACTURING | ATKINSON, JOSHUA ALEXANDER | 1612 | DPOther | Final Rejection | — | Pending | Feb 13, 2023 |
| 18041470 | TEXAPHYRIN DERIVATIVES FOR MANGANESE CHEMOTHERAPY, PHOTOACOUSTIC IMAGING, AND PHOTOTHERMAL THERAPY | JONES, DAMERON LEVEST | 1618 | §103 | Final Rejection | 21d | Pending | Feb 13, 2023 |
| 18040586 | METHODS AND COMPOSITIONS FOR PANCREATIC CANCER EVALUATION AND TREATMENT | BUTTICE, AUDREY L | 1647 | §103 | Final Rejection | — | Pending | Feb 03, 2023 |
| 18018350 | SOLIDS ANALYSIS OF DRILLING AND COMPLETION FLUIDS | CULLER, JILL E | 2853 | §102§103 | Non-Final OA | 72d overdue | Pending | Jan 27, 2023 |
| 18006652 | ENGINEERED T CELLS AND TUMOR-INFILTRATING LYMPHOCYTES TO INCREASE TUMOR KILLING | BUTTICE, AUDREY L | 1647 | §103 | Non-Final OA | — | Pending | Jan 24, 2023 |
| 18155510 | HISTAMINE AND HRH1 SIGNALING ACTIVITY AS BIOMARKERS AND ASSOCIATED METHODS | CUNNINGCHEN, KATHLEEN MARY | 1646 | §102§103§112 | Final Rejection | 23d overdue | Pending | Jan 17, 2023 |
| 18094973 | NEIL2 PROTEIN THERAPY FOR TREATMENT OF VIRAL INFECTION | STEADMAN, DAVID J | 1656 | §103Other | Non-Final OA | 46d | Pending | Jan 09, 2023 |
| 18145602 | METHODS FOR THE DETECTION AND TREATMENT OF PROSTATE CANCER | XU, XIAOYUN | 1797 | §101 | Non-Final OA | — | Pending | Dec 22, 2022 |
| 18145595 | UREA INHIBITORS OF MICRO-RNA | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §103 | Non-Final OA | 53d overdue | Pending | Dec 22, 2022 |
| 18010456 | PROCESSES AND APPLICATIONS FOR CATALYST INFLUENCED CHEMICAL ETCHING | PETERSON, ERIK T | 2898 | §102§112 | Final Rejection | 84d overdue | Pending | Dec 15, 2022 |
| 18001425 | MOLECULAR MARKERS AND METHODS FOR SAMPLE ANALYSIS VIA MASS SPECTROMETRY | TURPIN, ZACHARY MARK | 1682 | §103§112 | Final Rejection | — | Pending | Dec 09, 2022 |
| 18076315 | OMICRON SARS-COV-2 ASSAY | BLUMEL, BENJAMIN P | 1671 | §102§103§112 | Final Rejection | 63d | Pending | Dec 06, 2022 |
| 18000414 | LARGE-SCALE PRODUCTION OF EXOSOMES FROM PRIMED MESENCHYMAL STROMAL CELLS FOR CLINICAL USE | EBBINGHAUS, BRIANA NOEL | 1632 | §112DP | Final Rejection | 4d overdue | Pending | Dec 01, 2022 |
| 18072100 | System, Kit and Apparatus for Attachment of External Fixators for Bone Realignment | COTRONEO, STEVEN J | 3773 | §103 | Non-Final OA | — | Pending | Nov 30, 2022 |
| 18059180 | SYSTEM AND METHODS FOR INCREASING SYNTHESIZED PROTEIN STABILITY | ALLEN, MARIANNE P | 1672 | §102§103§112Other | Non-Final OA | — | Pending | Nov 28, 2022 |
| 18059196 | SYSTEM AND METHODS FOR INCREASING SYNTHESIZED PROTEIN STABILITY | LUO, JAMMY NMN | 1686 | §101§103§112 | Non-Final OA | — | Pending | Nov 28, 2022 |
| 18056970 | METHODS, SYSTEMS AND KITS FOR POLYPEPTIDE PROCESSING AND ANALYSIS | BOESEN, CHRISTIAN C | 1684 | §102§112 | Non-Final OA | — | Pending | Nov 18, 2022 |
| 17923473 | NANOFABRICATION OF COLLAPSE-FREE HIGH ASPECT RATIO NANOSTRUCTURES | KIM, JAHAE | 2897 | §102§103§112 | Non-Final OA | — | Pending | Nov 04, 2022 |
| 17997453 | ALBUMIN DRUG CONJUGATES AND USE THEREOF FOR THE TREATMENT OF CANCER | LEE, JAE W | 1656 | §103 | Final Rejection | 9d overdue | Pending | Oct 28, 2022 |
| 17996828 | METHODS FOR TREATING BLADDER CANCER | BELYAVSKYI, MICHAIL A | 1644 | §103 | Final Rejection | — | Pending | Oct 21, 2022 |
| 17969740 | COXIELLA BURNETII AVIRULENT NINE MILE PHASE II VIABLE BACTERIA AND METHODS OF USE | MORGAN, BAILEY MICHELLE | 1645 | §103 | Non-Final OA | 119d overdue | Pending | Oct 20, 2022 |
| 17996618 | LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF | LIPPERT, JOHN WILLIAM | 1615 | §103 | Final Rejection | 14d | Pending | Oct 19, 2022 |
| 17960557 | GOLF SHAFTS HAVING A VARYING OUTER DIAMETER, INNER DIAMETER, AND/OR WALL THICKNESS AND METHODS FOR MANUFACTURING GOLF SHAFTS USING ADDITIVE MANUFACTURING | PAIK, STEVEN SANGYUL | 2876 | §103§112 | Final Rejection | 5d overdue | Pending | Oct 05, 2022 |
| 17958203 | POSITIVE ACTIVE MATERIAL FOR RECHARGEABLE LITHIUM BATTERIES, PREPARATION METHOD THEREOF AND RECHARGEABLE LITHIUM BATTERIES | FEHR, JULIA MARIE | 1725 | §103 | Non-Final OA | — | Pending | Sep 30, 2022 |
| 17914735 | REVERSE GENETIC SYSTEM FOR SARS-COV-2 | FOLEY, SHANON A | 1671 | §103§112 | Non-Final OA | 42d overdue | Pending | Sep 26, 2022 |
| 17912680 | A CLASS OF ARTIFICIAL SEI LAYERS FOR STABILIZING LITHIUM DEPOSITION IN LITHIUM BATTERIES AND RELATED METHODS | HA, STEVEN S | 1735 | §103 | Final Rejection | — | Pending | Sep 19, 2022 |
| 17947899 | AUTOMATED METHOD AND SYSTEM FOR INTERPRETING TEST RESULTS | NEWTON, CHAD A | 3681 | §101§103 | Non-Final OA | — | Pending | Sep 19, 2022 |
| 17905124 | METHODS AND COMPOSITIONS FOR TREATMENT OF APC-DEFICIENT CANCER | JONES, DAMERON LEVEST | 1618 | §102§103§112 | Non-Final OA | — | Pending | Aug 26, 2022 |
| 17821931 | COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING EGFR OR HER2 EXON 20 MUTATIONS | ENGLISH, CONNOR KENNEDY | 1625 | §103 | Non-Final OA | — | Pending | Aug 24, 2022 |
| 17929013 | METHODS FOR RAPID CLONING AND EXPRESSION OF HLA CLASS I CELLS | QIAN, CELINE X | 1637 | §103 | Final Rejection | 51d overdue | Pending | Aug 10, 2022 |
| 17759817 | USE OF QUINAZOLINE-BASED TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCERS WITH NRG1 FUSIONS | RZECZYCKI, PHILLIP MATTHEW | 1625 | DP | Final Rejection | — | Pending | Jul 29, 2022 |
| 17814198 | T CELLS EXPRESSING MEMBRANE-ANCHORED IL-12 FOR THE TREATMENT OF CANCER | LIU, SUE XU | 1616 | §102§103DP | Non-Final OA | — | Pending | Jul 21, 2022 |
| 17786917 | METHODS FOR TREATING GLIOBLASTOMA | GODDARD, LAURA B | 1642 | §103§112 | Final Rejection | 40d | Pending | Jun 17, 2022 |
| 17782976 | EXOSOMES-BASED THERAPY FOR LIVER FIBROSIS AND OTHER DISEASES WITH FIBROSIS | CHONG, KIMBERLY | 1636 | §103 | Final Rejection | 66d overdue | Pending | Jun 06, 2022 |
| 17782147 | COMBINATION THERAPIES FOR THE TREATMENT OF CANCER | JONES, DAMERON LEVEST | 1618 | §103§112 | Non-Final OA | 39d | Pending | Jun 02, 2022 |
| 17756116 | LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF MSC CELLS | SPENCE, JENNIFER SUZANNE | 1633 | §103 | Non-Final OA | 46d overdue | Pending | May 17, 2022 |
| 17756078 | LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF T CELLS | KONOPKA, CATHERINE ANNE | 1635 | §103§112DP | Final Rejection | 20d | Pending | May 16, 2022 |
| 17776803 | COMPOSITIONS AND METHODS FOR CONTROLLED DELIVERY AND PROTECTION OF THERAPEUTIC AGENTS | PRAGANI, RAJAN | 1614 | §103§112 | Final Rejection | — | Pending | May 13, 2022 |
| 17755881 | NATURAL KILLER CELL IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS | EBBINGHAUS, BRIANA NOEL | 1632 | §101§102§112Other | Non-Final OA | 217d overdue | Pending | May 11, 2022 |
| 17774838 | METHODS FOR THE TREATMENT OF DYSMYELINATING/DEMYELINATING DISEASES | NEAGU, IRINA | 1629 | §103 | Final Rejection | — | Pending | May 05, 2022 |
| 17773682 | TARGETING NONSENSE-MEDIATED DECAY TO ACTIVATE P53 PATHWAY FOR THE TREATMENT OF CANCER | ZARA, JANE J | 1637 | §102§103§112 | Non-Final OA | — | Pending | May 02, 2022 |
| 17773491 | INTERNET OF THINGS SECURITY ANALYTICS AND SOLUTIONS WITH DEEP LEARNING | POPHAM, JEFFREY D | 2432 | §103§112 | Non-Final OA | 29d | Pending | Apr 29, 2022 |
| 17661057 | IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS | SPENCE, JENNIFER SUZANNE | 1633 | §102§103 | Non-Final OA | — | Pending | Apr 28, 2022 |
| 17771907 | SURFACE-STABILIZED LINIO2 AS HIGH CAPACITY CATHODE FOR LI ION BATTERIES | WALLS, CYNTHIA KYUNG SOO | 1751 | §103 | Final Rejection | 59d overdue | Pending | Apr 26, 2022 |
| 17764104 | IMMUNOGENIC EGFR PEPTIDE COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER | PATTERSON, SARAH COOPER | 1675 | §103§112 | Final Rejection | 43d overdue | Pending | Mar 25, 2022 |
| 17697375 | SYSTEMS AND METHODS FOR ELECTRICAL ENERGY STORAGE | ZHANG, HAIXIA | 1723 | §103 | Final Rejection | — | Pending | Mar 17, 2022 |
| 17633294 | ANTI-VIRAL CENTRAL MEMORY CD8+ VETO CELLS IN HAPLOIDENTICAL STEM CELL TRANSPLANTATION | SPENCE, JENNIFER SUZANNE | 1633 | §103§112 | Non-Final OA | — | Pending | Feb 07, 2022 |
| 17568619 | BK CHANNEL-MODULATING PEPTIDES AND THEIR USE | BALLARD, KIMBERLY | 1675 | §102§112Other | Non-Final OA | 28d | Pending | Jan 04, 2022 |
| 17620605 | METHODS FOR DUPLEX SEQUENCING OF CELL-FREE DNA AND APPLICATIONS THEREOF | PARISI, JESSICA DANIELLE | 1684 | §103 | Final Rejection | — | Pending | Dec 17, 2021 |
| 17615393 | A SEMILIQUID SURFACE WITH LIQUID AND SOLID REPELLENCE | NELSON, MICHAEL B | 1787 | §103 | Final Rejection | 2d overdue | Pending | Nov 30, 2021 |
| 17613292 | INHIBITOR OF MNK FOR THE TREATMENT OF NEUROPATHIC PAIN | AGGARWAL, SAHIL CHANDER | 1623 | §103§112DP | Non-Final OA | — | Pending | Nov 22, 2021 |
| 17611929 | RADIOTHERAPEUTIC MICROSPHERES | YOUNG, MICAH PAUL | 1618 | §102Other | Non-Final OA | 21d | Pending | Nov 17, 2021 |
| 17611019 | METHODS AND COMPOSITIONS FOR TREATING NON-SMALL CELL LUNG CANCER | HAM, JIEUN | 1643 | §112 | Non-Final OA | 30d | Pending | Nov 12, 2021 |
| 17608025 | METHODS AND COMPOSITIONS INVOLVING TERT ACTIVATING THERAPIES | REYNOLDS, FRED H | 1658 | §112 | Final Rejection | — | Pending | Nov 01, 2021 |
| 17601405 | METHODS AND APPLICATIONS FOR CELL BARCODING | RAYMONDA, MATTHEW HAROLD | 1684 | §103 | Non-Final OA | 20d | Pending | Oct 04, 2021 |
| 17600600 | COMBINATIONS OF TRANSCRIPTION INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF DISEASE | DONOGHUE, BRITTNEY ERIN | 1675 | §103§112 | Non-Final OA | 19d overdue | Pending | Sep 30, 2021 |
| 17598780 | NUCLEAR-DERIVED EXOSOMES AND METHODS OF USE THEREOF | SKOKO III, JOHN JOSEPH | 1643 | §101§103§112 | Final Rejection | 27d | Pending | Sep 27, 2021 |
| 17471717 | RESONANT FILTERS HAVING SIMULTANEOUSLY TUNED CENTRAL WAVELENGTHS AND SIDEBANDS | HAYES, MARY A | 2874 | §103 | Final Rejection | 14d | Pending | Sep 10, 2021 |
| 17412900 | Stable Reporter Flavivirus | SIFFORD, JEFFREY MARK | 1671 | §112 | Non-Final OA | 30d | Pending | Aug 26, 2021 |
| 17431813 | BEE GUT MICROBIAL FORMULATION FOR USE AS A PROBIOTIC FOR IMPROVED BEE HEALTH AND PATHOGEN RESISTANCE | EIX, EMILY FAY | 1653 | §103§112 | Non-Final OA | 12d | Pending | Aug 18, 2021 |
| 17416227 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | DENT, ALANA HARRIS | 1643 | §102§103 | Final Rejection | — | Pending | Jun 18, 2021 |
| 17331723 | ELECTROANALYTICAL DETERMINATION OF LEUKOCYTE ESTERASE | GORDON, MELENIE LEE | 1651 | §103 | Final Rejection | — | Pending | May 27, 2021 |
| 17289307 | COMPOSITE FILMS AND METHODS OF MAKING AND USE THEREOF | DICUS, TAMRA | 1787 | §103 | Non-Final OA | — | Pending | Apr 28, 2021 |
| 17235771 | BIOLOGICALLY ACTIVE DRY POWDER COMPOSITIONS AND METHOD OF THEIR MANUFACTURE AND USE | NGUYEN, JOHN P | 1619 | §103 | Final Rejection | 17d overdue | Pending | Apr 20, 2021 |
| 17285908 | COMPOSITIONS FOR AND METHODS OF PRODUCING TUMOR ORGANOIDS | KASAYAN, KATRIEL BARCELLANO | 1600 | §103§112 | Non-Final OA | — | Pending | Apr 15, 2021 |
| 17222924 | SYSTEM AND METHOD FOR HUMAN ACTION RECOGNITION AND INTENSITY INDEXING FROM VIDEO STREAM USING FUZZY ATTENTION MACHINE LEARNING | SMITH, KEVIN LEE | 2122 | §101 | Final Rejection | 66d overdue | Pending | Apr 05, 2021 |
| 17193511 | TREATMENT OF BRAIN CANCER WITH ONCOLYTIC ADENOVIRUS | GODDARD, LAURA B | 1642 | DP | Final Rejection | — | Pending | Mar 05, 2021 |
| 17050775 | NATURAL KILLER CELLS ENGINEERED TO EXPRESS CHIMERIC ANTIGEN RECEPTORS WITH IMMUNE CHECKPOINT BLOCKADE | BALLARD, KIMBERLY | 1675 | §103 | Final Rejection | — | Pending | Oct 26, 2020 |
| 16980128 | IMMUNO-EXOSOMES AND METHODS OF USE THEREOF | GAO, ASHLEY HARTMAN | 1678 | §103§112 | Final Rejection | — | Pending | Sep 11, 2020 |
| 18933931 | IMAGING SYSTEM AND METHOD TO CONVERT LATERAL SCANNING INTO AXIAL REMOTE FOCUSING | BOYLAN, JAMES T | 2486 | §103Other | Final Rejection | 2d overdue | Pending | Oct 31, 2024 |
| 18829953 | QUINOLINE cGAS ANTAGONIST COMPOUNDS | SEAMAN, D MARGARET M | — | DP | Non-Final OA | — | Pending | Sep 10, 2024 |
| 18833074 | DORSAL MEDULLA SURFACE TEXTURE AS AN IMAGING METRIC TO DISTINGUISH BETWEEN NEUROLOGICAL DISORDERS SYSTEMS AND METHODS | KELLEY, CHRISTOPHER S | — | §103 | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18784134 | METHODS FOR HIGH-PERFORMANCE ELECTRON MICROSCOPY | LEMIEUX, IAN L | 2669 | §101§112 | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18710555 | ULTRA PH-SENSITIVE MICELLES ENCAPSULATING CYTOKINES FOR TREATMENT OF CANCER | CRAIGO, WILLIAM A | 1615 | §103§112 | Non-Final OA | — | Pending | May 15, 2024 |
| 18653847 | ONCOLYTIC VIRUSES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CANCER | VIVLEMORE, TRACY ANN | 1638 | §103 | Non-Final OA | — | Pending | May 02, 2024 |
| 18705047 | INTRA-OPERATIVELY FITTED ANTIBIOTIC SPACER SYSTEM | FLORES, ADRIAN | — | §102§103 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18639315 | METAL NANOPARTICLE ENHANCED SEMICONDUCTOR FILM FOR FUNCTIONALIZED TEXTILES | TATESURE, VINCENT | 1786 | §102§103 | Non-Final OA | — | Pending | Apr 18, 2024 |
| 18701806 | AI-ASSISTED CLINICIAN CONTOUR REVIEWING AND REVISION | POTTS, RYAN PATRICK | 2672 | §103 | Final Rejection | 16d overdue | Pending | Apr 16, 2024 |
| 18697643 | OPTICAL ROTATOR SYSTEMS AND METHODS | MUHAMMAD, KEY | 2872 | §102§103§112 | Non-Final OA | — | Pending | Apr 01, 2024 |
| 18686802 | BETA ADRENERGIC RECEPTOR COMPOSITIONS AND METHODS OF USE THEREOF | COUGHLIN, MATTHEW P | 1626 | §103§112 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18684645 | HETEROCYCLIC COMPOUNDS AS SEROTONIN (5-HT) 5-HT2A AND 5-HT2C RECEPTOR POSITIVE ALLOSTERIC MODULATORS | BORI, IBRAHIM D | 1629 | §103§112 | Final Rejection | — | Pending | Feb 16, 2024 |
| 18683101 | SLC13A5 GENE THERAPY VECTORS AND USES THEREOF | PRONZATI, GINA | 1633 | Other | Non-Final OA | — | Pending | Feb 12, 2024 |
| 18430270 | PRO-ICTAL STATE CLASSIFIER | ROZANSKI, GRACE NMN | 3791 | §101§103 | Final Rejection | 29d | Pending | Feb 01, 2024 |
| 18419370 | COMPOSITIONS, METHODS AND USES FOR TREATING CYSTIC FIBROSIS AND RELATED DISORDERS | VANHORN, ABIGAIL LOUISE | — | §103§112DP | Non-Final OA | — | Pending | Jan 22, 2024 |
| 18409612 | METHODS AND COMPOSITIONS FOR MUTAGENESIS SCREENING IN MAMMALIAN CELLS | TSUI, YUNG-SHENG M | — | §102§103 | Non-Final OA | — | Pending | Jan 10, 2024 |
| 18563790 | CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY MUTATIONS WITH ALL-IN-ONE ADENO-ASSOCIATED VIRUS-DELIVERED SINGLE-CUT CRISPR | ALLEN, SARAH ELIZABETH | — | §102§103§112 | Non-Final OA | — | Pending | Nov 22, 2023 |
| 18561044 | POLY-ADP RIBOSE (PAR) TRACKER OPTIMIZED SPLIT-PROTEIN REASSEMBLY PAR DETECTION REAGENTS | GODDARD, LAURA B | 1618 | §102§103§112 | Non-Final OA | — | Pending | Nov 15, 2023 |
| 18504868 | METHODS OF PREDICTING AND TREATING IMMUNOTHERAPY TOXICITY BASED ON IMMUNE CELL POPULATIONS | DAUNER, JOSEPH G | 1682 | §103§112 | Non-Final OA | — | Pending | Nov 08, 2023 |
| 18490131 | ALLELE SELECTIVE INHIBITION OF MUTANT C9ORF72 FOCI EXPRESSION BY DUPLEX RNAS TARGETING THE EXPANDED HEXANUCLEOTIDE REPEAT | CHONG, KIMBERLY | — | §103§112DP | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18286855 | DETECTION OF SARS-COV-2 VARIANT | KINSEY WHITE, NICOLE ERIN | 1672 | §112 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18552262 | NUCLEOTIDE EDITING TO REFRAME DMD TRANSCRIPTS BY BASE EDITING AND PRIME EDITING | CORDAS, EMILY ANN | 1632 | §103§112 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18283615 | COMPOSITIONS AND METHODS FOR TARGETED SYSTEMIC DELIVERY TO CELLS | ZARA, JANE J | 1637 | §112 | Non-Final OA | — | Pending | Sep 22, 2023 |
| 18283406 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | RONEY, CELESTE A | 1612 | §103DP | Non-Final OA | — | Pending | Sep 21, 2023 |
| 18283344 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | FUBARA, BLESSING M | 1613 | §103§112DP | Non-Final OA | — | Pending | Sep 21, 2023 |
| 18471280 | COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA | CHONG, KIMBERLY | 1636 | §103§112 | Non-Final OA | — | Pending | Sep 20, 2023 |
| 18281085 | METHODS FOR RECONSTITUTING T CELL SELECTION AND USES THEREOF | LEVERETT, MARY CHANG | — | §101§112 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18547408 | MAGNETIC SHEAR BIOREACTOR APPARATUS AND METHODS | BOWERS, NATHAN ANDREW | 1799 | §102§103 | Non-Final OA | 62d | Pending | Aug 22, 2023 |
| 18449675 | LIBRARY OF PH RESPONSIVE POLYMERS AND NANOPROBES THEREOF | LAZARO, DOMINIC | 1611 | §102§103§112DP | Non-Final OA | — | Pending | Aug 14, 2023 |
| 18264413 | INTRAMOLECULAR CYCLIZATION FOR GENERAL SYNTHESIS OF BICYCLIC ALKYL BIOISOSTERE BORONATES | O DELL, DAVID K | 1621 | §112 | Non-Final OA | 53d | Pending | Aug 04, 2023 |
| 18220864 | COMBINATION THERAPEUTICS USING TUMOR TREATING FIELDS (TTFIELDS) | GOUGH, TIFFANY MAUREEN | 1651 | §103§112DP | Final Rejection | 45d overdue | Pending | Jul 12, 2023 |
| 18271173 | ENGINEERED STABLE ACE2 PROTEIN VARIANTS AS ANTIVIRAL NEBULIZED THERAPEUTICS | CHANDRA, GYAN | 1674 | §102§112 | Final Rejection | 70d | Pending | Jul 06, 2023 |
| 18266712 | TAU BIOSENSOR CELL LINES | WESTON, ALYSSA G | 1633 | §102§103§112 | Non-Final OA | — | Pending | Jun 12, 2023 |
| 18265226 | COMPOSITIONS TARGETING WDR37 AND METHODS OF USE THEREOF | KONOPKA, CATHERINE ANNE | 1635 | §102§103§112 | Non-Final OA | 3d overdue | Pending | Jun 02, 2023 |
| 18196262 | TUBE SECUREMENT DEVICE AND METHODS | RITCHIE, HADEN MATTHEW | 3783 | §102 | Non-Final OA | — | Pending | May 11, 2023 |
| 18249864 | HIGH THROUGHPUT CELL MIGRATION ASSAY PLATES AND METHODS OF FABRICATION | HANDY, DWAYNE K | 1798 | §103 | Final Rejection | — | Pending | Apr 20, 2023 |
| 18032760 | PROINFLAMMATORY PRODRUGS | MEJIAS, SAMANTHA LEE | 1618 | §102§103§112 | Non-Final OA | 71d | Pending | Apr 19, 2023 |
| 18249661 | METHODS FOR GENERATING FORMATIVE PLURIPOTENT STEM CELLS COMPETENT FOR DIRECT PRIMORDIAL GERM CELL INDUCTION | MONTANARI, DAVID A | 1632 | §112 | Final Rejection | 8d overdue | Pending | Apr 19, 2023 |
| 18026696 | THERAPEUTIC AGENTS AND USES THEREOF | HOWARD, ZACHARY C | 1674 | §102§112Other | Non-Final OA | — | Pending | Mar 16, 2023 |
| 18042231 | COMBINATION IMMUNOTHERAPY METHODS FOR THE TREATMENT OF CANCER | MORGAN, BAILEY MICHELLE | 1645 | §103 | Final Rejection | — | Pending | Feb 20, 2023 |
| 18004522 | ADENO-ASSOCIATED VIRUS VECTOR FOR DWARF OPEN READING FRAME | MOLOYE, TITILAYO | 1632 | §103 | Final Rejection | — | Pending | Jan 06, 2023 |
| 18014850 | TDP-43 BIOSENSOR CELL LINES | KASAYAN, KATRIEL BARCELLANO | 1634 | §112 | Final Rejection | 31d overdue | Pending | Jan 06, 2023 |
| 18069796 | ENCAPSULATION OF BIOACTIVE INGREDIENTS BY MULTIPLEX EMULSION | STEINKE, SEAN JAMES | 1619 | §103§112 | Final Rejection | 73d overdue | Pending | Dec 21, 2022 |
| 18062937 | PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY | HALVORSON, MARK | 1646 | §103Other | Final Rejection | 22d overdue | Pending | Dec 07, 2022 |
| 17998037 | SYSTEMS AND METHODS FOR CHARACTERIZING A TUMOR MICROENVIRONMENT USING PATHOLOGICAL IMAGES | SHARIFF, MICHAEL ADAM | 2672 | §103§112 | Final Rejection | 46d overdue | Pending | Nov 06, 2022 |
| 18050687 | USE OF FATE MODULATORS TO IMPROVE NERVE REGENERATION | MCCORMICK, CATHERINE LYNN | 1638 | §103§112 | Final Rejection | — | Pending | Oct 28, 2022 |
| 17912485 | SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1 | YOO, SUN JAE | 1621 | §102§112 | Final Rejection | — | Pending | Sep 16, 2022 |
| 17905285 | METHOD FOR DIAGNOSIS AND/OR PROGNOSIS OF LIVER DISEASE PROGRESSION AND RISK OF HEPATOCELLULAR CARCINOMA AND DISCOVERY OF THERAPEUTIC COMPOUNDS AND TARGETS TO TREAT LIVER DISEASE AND CANCER | HUDSON, AMY ROSE | 1636 | §101§103§112 | Non-Final OA | — | Pending | Aug 30, 2022 |
| 17889946 | SYSTEMS, METHODS, AND APPARATUSES TO PROVIDE CHEST TUBE INSERTION FEEDBACK | ALSOMAIRY, SELWA ABDO | 3715 | §101§112 | Non-Final OA | — | Pending | Aug 17, 2022 |
| 17782402 | URINE ANALYSIS DEVICES AND METHODS FOR REAL TIME MONITORING OF KIDNEY FUNCTION | WESTFALL, SARAH ANN | 3791 | §102§112 | Non-Final OA | — | Pending | Jun 03, 2022 |
| 17672346 | FCRN ANTAGONISTS AND METHODS OF USE | DAHLE, CHUN WU | 1641 | Other | Final Rejection | — | Pending | Feb 15, 2022 |
| 17586258 | MUTANTS AND DRUG CONJUGATES OF R-SPONDINS AND USE THEREOF | REYNOLDS, FRED H | 1658 | §112 | Final Rejection | — | Pending | Jan 27, 2022 |
| 17048953 | Compositions and Methods for Diagnosis and Treatment of Endometriosis | MUMMERT, STEPHANIE KANE | 1681 | §102§103 | Non-Final OA | 40d | Pending | Oct 19, 2020 |
| 18318062 | ENDOLYSOSOMAL TARGETING CONJUGATES FOR IMPROVED DELIVERY OF CARGO MOLECULES TO THE ENDOLYSOSOMAL COMPARTMENT OF TARGET CELLS | DUFFY, PATRICIA ANN | 1645 | §102§112 | Non-Final OA | — | Pending | May 16, 2023 |
| 18250532 | DIRECTIONAL AND SCALABLE ELECTRODE ARRAY | PORTER, JR, GARY A | 3796 | §102§103 | Final Rejection | 16d overdue | Pending | Apr 25, 2023 |
| 18027993 | DISCOVERY AND USE OF IMMUNOGENIC PEPTIDES FOR THE TREATMENT AND PREVENTION OF CANCERS | STOICA, ELLY GERALD | 1647 | §102§112 | Non-Final OA | 11d overdue | Pending | Mar 23, 2023 |
| 17440993 | COMPUTERIZED SYSTEM AND METHOD FOR ANTIGEN-INDEPENDENT DE NOVO PREDICTION OF CANCER-ASSOCIATED TCR REPERTOIRE | KALLAL, ROBERT JAMES | 1685 | §101 | Non-Final OA | — | Pending | Sep 20, 2021 |
| 17353587 | METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS | MARVICH, MARIA | 1634 | §103Other | Final Rejection | 54d | Pending | Jun 21, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial